Operose Advisors’s Adient ADNT Stock Holding History

Operose Advisors’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27	Closed	-$609	–	429
2024 Q3	$609	Hold	27	–	–	﹤0.01%	601
2024 Q2	$667	Hold	27	–	–	﹤0.01%	570
2024 Q1	$889	Buy	+27	New	+$919	﹤0.01%	622

Other funds holding ADNT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Operose Advisors's ADNT Position: Q4 2024 in Review

Operose Advisors sold out of Adient (ADNT) in Q4 2024, closing a stake of 27 shares — an estimated $609 sold.

Operose Advisors first reported a position in ADNT in Q1 2024 and held it in 3 quarters. The position peaked at $889 in Q1 2024. 270 funds tracked by Wall St. Rank hold ADNT as of Q4 2024.

Operose Advisors reported no remaining Adient position as of Q4 2024 after selling out during the quarter.
Operose Advisors sold 27 Adient shares in Q4 2024, an estimated $609.
Operose Advisors first reported a position in Adient in Q1 2024 and held it in 3 quarters.
Operose Advisors's Adient position peaked at $889 in Q1 2024.
270 funds tracked by Wall St. Rank held Adient as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.